检索结果 - Nikola Bangemann

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes

    Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes 由 Gerhard Schäller, Ilka Fuchs, Thomas Gonsch, Jan Weber, Anke Kleine-Tebbe, Peter Klare, Hans-Joachim Hindenburg, Volker Lakner, Axel Hinke, Nikola Bangemann

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy

    Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy 由 Petra Huehnchen, Christian Schinke, Nikola Bangemann, Adam Dordevic, Johannes S. Kern, Smilla K. Maierhof, Lois Hew, Luca Nolte, Peter Körtvélyessy, Jens Göpfert, Klemens Ruprecht, Christopher J. Somps, Jens‐Uwe Blohmer, Jalid Sehouli, Matthias Endres, Wolfgang Boehmerle

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions

    The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions 由 Berit Müller, E. Keil, Annika Lehmann, Klaus-Jürgen Winzer, Christiane Richter-Ehrenstein, Judith Prinzler, Nikola Bangemann, Angela Reles, Sylvia Stadie, Winfried Schoenegg, Jan Eucker, Marcus Schmidt, Frank Lippek, Korinna Jöhrens, Stefan Pahl, Bruno V. Sinn, Jan Budczies, Manfred Dietel, Carsten Denkert

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results

    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results 由 Oleg Gluz, Ulrike Nitz, Cornelia Liedtke, Matthias Christgen, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Nikola Bangemann, Christoph Lindner, Sherko Küemmel, Michael Clemens, Jochem Potenberg, Peter Staib, A. Kohls, Raquel von Schumann, Ronald Kates, Ronald Kates, Johannes Schumacher, Rachel Wuerstlein, Hans Kreipe, Nadia Harbeck

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: